These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20862279)

  • 1. Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.
    Uhler LM; Kumarasamy N; Mayer KH; Saxena A; Losina E; Muniyandi M; Stoler AW; Lu Z; Walensky RP; Flanigan TP; Bender MA; Freedberg KA; Swaminathan S;
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
    Freedberg KA; Kumarasamy N; Losina E; Cecelia AJ; Scott CA; Divi N; Flanigan TP; Lu Z; Weinstein MC; Wang B; Ganesh AK; Bender MA; Mayer KH; Walensky RP
    AIDS; 2007 Jul; 21 Suppl 4(Suppl 4):S117-28. PubMed ID: 17620747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.
    Venkatesh KK; Becker JE; Kumarasamy N; Nakamura YM; Mayer KH; Losina E; Swaminathan S; Flanigan TP; Walensky RP; Freedberg KA
    PLoS One; 2013; 8(5):e64604. PubMed ID: 23741348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.
    Pho MT; Swaminathan S; Kumarasamy N; Losina E; Ponnuraja C; Uhler LM; Scott CA; Mayer KH; Freedberg KA; Walensky RP
    PLoS One; 2012; 7(4):e36001. PubMed ID: 22558301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.
    Lee DJ; Kumarasamy N; Resch SC; Sivaramakrishnan GN; Mayer KH; Tripathy S; Paltiel AD; Freedberg KA; Reddy KP
    PLoS One; 2019; 14(7):e0218890. PubMed ID: 31265470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa.
    Naidoo K; Grobler AC; Deghaye N; Reddy T; Gengiah S; Gray A; Abdool Karim S
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):576-84. PubMed ID: 26167618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.
    Levison JH; Wood R; Scott CA; Ciaranello AL; Martinson NA; Rusu C; Losina E; Freedberg KA; Walensky RP
    Clin Infect Dis; 2013 Feb; 56(4):587-97. PubMed ID: 23087386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis.
    MacPherson P; Webb EL; Kamchedzera W; Joekes E; Mjoli G; Lalloo DG; Divala TH; Choko AT; Burke RM; Maheswaran H; Pai M; Squire SB; Nliwasa M; Corbett EL
    PLoS Med; 2021 Sep; 18(9):e1003752. PubMed ID: 34499665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India.
    Kazemian P; Costantini S; Kumarasamy N; Paltiel AD; Mayer KH; Chandhiok N; Walensky RP; Freedberg KA
    Clin Infect Dis; 2020 Feb; 70(4):633-642. PubMed ID: 30921454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.
    Freedberg KA; Kumarasamy N; Borre ED; Ross EL; Mayer KH; Losina E; Swaminathan S; Flanigan TP; Walensky RP
    AIDS Res Hum Retroviruses; 2018 Jun; 34(6):486-497. PubMed ID: 29620932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.
    Schackman BR; Scott CA; Walensky RP; Losina E; Freedberg KA; Sax PE
    AIDS; 2008 Oct; 22(15):2025-33. PubMed ID: 18784465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness and total costs of three alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of Human Immunodeficiency Virus positive patients with tuberculosis in Kenya.
    van Gorkom J; Kibuga DK
    Tuber Lung Dis; 1996 Feb; 77(1):30-6. PubMed ID: 8733411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent Tuberculosis Infection Testing Strategies for HIV-Positive Individuals in Hong Kong.
    Wong NS; Chan KCW; Wong BCK; Leung CC; Chan WK; Lin AWC; Lui GCY; Mitchell KM; Lee SS
    JAMA Netw Open; 2019 Sep; 2(9):e1910960. PubMed ID: 31490541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
    Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
    PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of provider-initiated HIV testing and counselling of tuberculosis patients under the TB control programme in two districts of South India.
    Vijay S; Swaminathan S; Vaidyanathan P; Thomas A; Chauhan LS; Kumar P; Chiddarwar S; Thomas B; Dewan PK
    PLoS One; 2009 Nov; 4(11):e7899. PubMed ID: 19936067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.
    Ciaranello AL; Doherty K; Penazzato M; Lindsey JC; Harrison L; Kelly K; Walensky RP; Essajee S; Losina E; Muhe L; Wools-Kaloustian K; Ayaya S; Weinstein MC; Palumbo P; Freedberg KA
    AIDS; 2015 Jun; 29(10):1247-59. PubMed ID: 25870982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti.
    Koenig SP; Bang H; Severe P; Jean Juste MA; Ambroise A; Edwards A; Hippolyte J; Fitzgerald DW; McGreevy J; Riviere C; Marcelin S; Secours R; Johnson WD; Pape JW; Schackman BR
    PLoS Med; 2011 Sep; 8(9):e1001095. PubMed ID: 21949643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV: A Systematic Literature Review.
    de Siqueira-Filha NT; Legood R; Cavalcanti A; Santos AC
    Value Health; 2018 Apr; 21(4):482-490. PubMed ID: 29680106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of tuberculosis patients on provider-initiated HIV testing and counseling--a study from south India.
    Thomas BE; Dewan PK; Vijay S; Thomas A; Chauhan LS; Vedachalam C; Vaidyanathan P; Swaminathan S
    PLoS One; 2009 Dec; 4(12):e8389. PubMed ID: 20041167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial.
    Schackman BR; Metsch LR; Colfax GN; Leff JA; Wong A; Scott CA; Feaster DJ; Gooden L; Matheson T; Haynes LF; Paltiel AD; Walensky RP
    Drug Alcohol Depend; 2013 Feb; 128(1-2):90-7. PubMed ID: 22971593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.